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http://dx.doi.org/10.1016/j.jmii.2014
1684-1182/Copyright ª 2014, TaiwanBackground: Coinfection with respiratory virus and Streptococcus pneumoniae has been
frequently reported in several epidemiologic studies. The aim of this study was to explore
the effect of preceding human metapneumovirus (hMPV) inoculation on subsequent pneumo-
coccal infection.
Methods: Hep-2 and A549 cells were infected with hMPV then inoculated with S. pneumoniae.
Bacterial adhesion was measured using colony forming unit and cytometric-fluorescence as-
says. In vivo bacterial adhesion was examined in hMPV-infected mice after inoculation of
fluorescence-conjugated S. pneumoniae. Pulmonary inflammation (bacterial titers, cytokine
levels, and histopathology) of hMPV-infected mice was investigated after inoculation with S.
pneumoniae.
Results: In vitro results of bacterial infection with S. pneumoniae on A549 and Hep-2 mono-
layer cells showed that even though cellular adherence was variable among different sero-
types, there was significantly enhanced bacterial adherence in A549 cells with preceding
hMPV infection. In addition, in vivo study of hMPV-infected mice showed increased adhesion
of S. pneumoniae on the bronchial epithelium with delayed bacterial clearance and exacer-
bated histopathology. Furthermore, mice with preceding hMPV infection showed repressed
recruitment of airway neutrophils with decreased expression of neutrophil chemoattractants
during pneumococcal infection.of Pediatrics, Chang Gung Memorial Hospital, 5 Fu-Hsing Street, Kwei-Shan, Taoyuan, Taiwan.
org.tw (T.-Y. Lin).
.04.008
Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
hMPV increase adherence of Pneumococcus 217Conclusion: These results suggest that hMPV-infected airway cells, especially the lower airway
epithelium, express increased adherence with S. pneumoniae. Furthermore, hMPV-infected
mice showed impaired recruitment of airway neutrophils, possibly leading to delayed bacterial
clearance and exacerbated pulmonary inflammation, after secondary infection with pneumo-
coccal isolates.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Streptococcus pneumoniae is a common cause of invasive
disease and respiratory tract infections and is among the
most common pathogens of community-acquired pneu-
monia in children.1e3 Human metapneumovirus (hMPV) is a
new member of the genus Metapneumovirus. hMPV was
first identified in respiratory specimens obtained from
young children with various respiratory syndromes,4 and
this virus is genetically and clinically similar to respiratory
syncytial virus (RSV). hMPV and RSV are among the most
common pathogens causing lower airway infection during
infancy.5
S. pneumoniae can be easily isolated from the naso-
pharyngeal airway of healthy children.6 Colonization of S.
pneumoniae is common in children, and invasion into the
respiratory tract requires bacterial adherence to the
epithelial lining of the airway. Reports have shown that
preceding or even simultaneous infections with a respi-
ratory virus, including influenza virus, RSV, parainfluenza
virus, rhinovirus, and adenovirus, occur during pneumo-
coccal disease.1e3 The concept of a respiratory virus
predisposing to a bacterial infection was first considered
during the influenza pandemic in 1918. Decreased pul-
monary clearance of S. pneumoniae and significant lethal
synergism have been observed after influenza infection in
animal models,7,8 which could be mediated by the neur-
aminidase on the capsid of the influenza virus.8,9
Enhanced adherence and decreased pulmonary clearance
of S. pneumoniae were also observed in several in vitro
and in vivo studies of RSV.10,11 It has been suggested that
viral G protein expressed on infected epithelial cells might
facilitate the adherence of S. pneumoniae.12 It has also
been observed that increasing expression of platelet-
activating factor receptor on respiratory epithelial cells
after RSV infection can enhance pneumococcal
adhesion.13
Several recent publications have reported coinfection
with hMPV and pneumococcus that resulted in exacerbated
pneumococcal pneumonia in mice.14e17 However, a
detailed effect of hMPV infection on subsequent pneumo-
coccal disease has not been studied. The aim of this study
was to clarify how hMPV infection causes further exacer-
bation of pneumococcal pneumonia while focusing on its
effect on bacterial adhesion and invasion. To our knowl-
edge, this is the first report to clarify that preceding hMPV
infection indeed augments in vitro and in vivo pneumo-
coccal adhesion, which explains the underlying mechanism
of decreased pulmonary clearance of S. pneumoniae in
hMPV-infected mice.Materials and methods
Cell cultures, hMPV, and S. pneumoniae
Hep-2 (ATCC CCL-23) and A549 cells (ATCC CCL-185) were
used for adhesion studies. The hMPV strain CAN97-83 was
obtained with kind permission from Dr Roberto P. Garofalo
(University of Texas Medical Branch, Galveston, TX, USA).
hMPV was propagated in LLC-MK2 cells and viral titer was
determined by a cell-based immunoassay.18 S. pneumoniae
serotype (ST) 3 and ST14 were attained from clinical sam-
ples and resuspended to a concentration of 108 colony-
forming units (CFU)/mL.12 To prepare the fluorescein
isothiocyanate-labeled S. pneumoniae (FITC-SP), the vital
bacteria were mixed with FITC and resuspended in a solu-
tion at a final concentration of 108 CFU/mL.10
CFU-based adhesion assay
A549 cells and Hep-2 cells were infected with hMPV at 1.0
multiplicity of infection (MOI) for 1 hour and incubated for
48 hours. The cells were then infected with S. pneumoniae
at 100 MOI and incubated for 30 minutes. After washing the
unbound bacteria, cells were then detached with cell
dissociation solution (Sigma-Aldrich, St Louis, MO, USA) and
resuspended. CFU of the original bacterial suspension (total
CFU) and of the suspension after the adherence assay (final
CFU) were estimated by the CFU-counting method.10 The
bacterial concentration (CFU/mL) was calculated as
CFU  dilution  10 (10 mL/spot). Adherence percentages
were calculated as final CFU/total CFU  100.
Cytometric fluorescence adhesion assay and
microscopic visualization of adhesion of FITC-SP
A549 cells in plates were infected with hMPV at 1.0 MOI for 1
hour and incubated for 48 hours. FITC-SP ST14 at 25 MOI was
then added after removing medium from hMPV-infected or
uninfected monolayers cells. The plates were spun to
facilitate attachment of bacteria, then incubated for 30
minutes. Cells were detached with cell dissociation solution
and fixed with formaldehyde. Cells adhered with FITC-SP
were counted and analyzed with a FACSCalibur instrument
using CellQuest (BD Bioscience, San Jose, CA, USA) software.
To visualize the adhesion of FITC-SP on cells, A549 cells
were inoculated with hMPV and subsequently with FITC-SP
ST14 as described above. Cells were then fixed and
observed under inverted confocal microscopy (TCS SP2
Leica Microsystems, Buffalo Grove, IL, USA).
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Female 4-week-old BALB/c mice, 14  2 g in weight, were
used for the in vivo experiments. The Animal Center of
Chang Gung Memorial Hospital approved all experiments.
Mice were inoculated with hMPV or phosphate-buffered
saline (PBS) 5 days before infection with S. pneumoniae.
For hMPV infection, each mouse was inoculated with
1.5  106 plaque-forming units of the virus. For S. pneu-
moniae infection, mice were infected with 1  106 CFU of
S. pneumoniae ST14. Mice were killed 24 hours or 48 hours
after S. pneumoniae infection, and analytic measurements
were then performed.
Localization of FITC-SP in respiratory epithelium
Mice were initially infected with hMPV or PBS as control and
inoculated with FITC-SP 5 days later. One hour after FITC-
SP inoculation, mice were killed and the lung was lavaged
with 1 mL PBS three times before the lungs were collected
and fixed with 3.7% buffered formaldehyde. The fixed lungs
were embedded in paraffin, sectioned in 5-mm slices, and
observed under fluorescence microscopy (DX50 Olympus,
Tokyo, Japan) to visualize in vivo adherence of S. pneu-
moniae on the respiratory epithelium.
Lung bacterial burden and bronchoalveolar lavage
Infected lungs were removed, weighed, and homogenized.
After serial dilutions, 100-mL aliquots of homogenate wereFigure 1. Adherence of Streptococcus pneumoniae on human
infected (SP). (A) A549; (B) Hep-2 cells. The figure shows the me
forming units (CFU) and inoculum percentage of adhering S. pneu
(n Z 6).quantified for bacterial counts. Data are expressed as CFU/
g of lung.
Cellular counts and differential cell counts were deter-
mined in bronchoalveolar lavage (BAL) fluid after being
stained with Liu’s stain. Supernatants were stored for
subsequent analysis of chemokines and cytokines.
Histopathology
For histopathologic analysis, lungs were collected on Day 1
or 2 after pneumococcal infection. Multiple 4-mm sections
were stained with hematoxylin and eosin. Slides were
analyzed and scored for tissue damage in a blinded fashion
under light microscopy as previously described.18 Inflam-
matory infiltrates were scored by enumerating the layers of
inflammatory cells surrounding the vessels and bronchioles.
The number of abnormal perivascular and peribronchial
spaces was divided by the total number of perivascular and
peribronchial spaces and reported as a percentage to pro-
vide a pathology score.
Cytokine and chemokine measurement
Chemokines and cytokines in BAL fluids were measured
by enzyme-linked immunosorbent assay according to
the manufacturer’s instructions. Reagents for interleukin
(IL)-1a, IL-10, interferon-g, and cytokine-induced neutro-
phil chemoattractant (KC) measurements were obtained
from R&D Systems (Minneapolis, MN, USA), and tumor
necrosis factor-a (TNF-a) and granulocyteemacrophagemetapneumovirus (hMPV)-infected (hMPV-SP) or nonehMPV-
an and standard deviation (positive value) of absolute colony-
moniae/107 CFU of inoculum. *p < 0.05 between two groups
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Biosciences (San Jose, CA, USA).
Statistical analysis
Statistical analyses were performed using the InStat3.05
biostatistics package (GraphPad, San Diego, CA, USA) and a
two-tailed, unpaired, ManneWhitney U test. Unless other-
wise indicated, themeanvalue standarddeviation is shown.
Results
hMPV infection increased in vitro and in vivo
cellular adhesion of S. pneumoniae
In A549 cells, adhesion of S. pneumoniae was significantly
increased in hMPV-infected cells (Fig. 1A). The mean per-
centage of adhering S. pneumoniae ST3 on hMPV-infected
and nonehMPV-infected A549 cells was 37.4% and 23.1%,
respectively (p < 0.05, Fig. 1A) and of S. pneumoniae ST14
was 33.6% and 13.5%, respectively (p < 0.05). In Hep-2
cells, although there was an increase in pneumococcal
adhesion in hMPV-infected cells as well (Fig. 1B), the
increment was not as striking as that of A549 cells.
S. pneumoniae was conjugated with FITC to enable
visualization of the amount of bacterial adherence onFigure 2. Adherence of fluorescein isothiocyanate-labeled (FITC
apneumovirus (hMPV)-infected (hMPV-SP) or non-hMPV-infected (SP
cells with adhered FITC-conjugated S. pneumoniae is shown. (B) Th
A549 cells were visualized using confocal microscopy.respiratory epithelial cells. Results from flow cytometry
showed that the positive FITC-signal ratio of hMPV-infected
A549 cells was higher than that of noninfected cells (42.9
vs. 19.5%; Fig. 2A). Similar results were observed from
confocal microscopy, showing an intense and condensed
fluorescence pattern in hMPV-infected cells. In contrast,
noninfected cells presented with a more discrete and
sparse pattern (Fig. 2B).
To analyze the adherence of S. pneumoniae in vivo, we
infected mice with FITC-labeled S. pneumoniae ST14 five
days after hMPV infection. Under fluorescence microscopy,
intense fluorescence signals were shown in the bronchial
epithelial cells of hMPV-infected mice, but only a few sig-
nals were found in the nonehMPV-infected mice (Fig. 3).
However, lower in the distal airway, the bronchiolar
epithelium showed little fluorescence in both hMPV-
infected and noninfected mice.
Decreased recruitment of airway neutrophils after
S. pneumoniae infection in mice with preceding
hMPV infection
Mice were initially inoculated with hMPV or PBS as controls
and subsequently infected with S. pneumoniae ST14 at Day 5
postinoculation. The total cell count in BAL fluid was higher
at 24 hours than at 48 hours postinfection (p < 0.05,
Fig. 4A). However, the total number of cells in the BAL fluid)-conjugated Streptococcus pneumoniae ST14 on human met-
) A549 cells. (A) Using flow cytometry, the percentage of A549
e adhered FITC-conjugated S. pneumoniae over the surface of
Figure 3. Adherence of fluorescein isothiocyanate-labeled (FITC)-conjugated Streptococcus pneumoniae on murine bronchial
epithelium. Mice were infected with human metapneumovirus (hMPV-SP) or phosphate buffered saline (SP) and 5 days later, were
inoculated with FITC-conjugated S. pneumoniae ST14. Under 20 magnification of light and fluorescence microscopy, enhanced
adherence of FITC-conjugated S. pneumoniae was visualized on bronchial epithelium of hMPV-SP mice.
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infection) was significantly higher than that of mice without
hMPV infection (p < 0.05, Fig. 4A). Further analysis of the
cellular differentials showed that the amount of neutrophils
recruited from hMPV-infected mice was significantly lower
than that of PBS-inoculated mice (p < 0.05, Fig. 4B).
Decreased bacterial clearance and deteriorated
histopathology in lungs of mice with previous hMPV
infection
Mice with preceding hMPV infection showed significantly
decreased clearance of S. pneumoniae in the lungs at 24
hours postinfection (p < 0.001). Although clearance of the
bacteria showed much improvement by 48 hours, the total
bacterial counts in the lungs of pre-hMPV-infected mice
were still higher than the counts of those that received PBS
alone (Fig. 5A).
Pulmonary histopathologic showed that the lungs with
preceding hMPV infection exhibited profound inflammation
in the peribronchial and perivascular area (Fig. 5B). The
histopathologic scores of the peribronchial and perivascular
area in mice with hMPV infection followed by S. pneumo-
niae infection were also significantly higher (Fig. 5C). The
severity of inflammation was greater at 48 hours after S.
pneumoniae infection (hMPV-SP vs. SP: peribronchial area,
87% vs. 75%; perivascular area, 72% vs. 57%).
Decreased levels of airway proinflammatory
cytokines after S. pneumoniae infection in mice
with previous hMPV infection
In general, levels of airway cytokine/chemokine signifi-
cantly waned at 48 hours after pneumococcal inoculation(Fig. 6). At either 24 hours or 48 hours after pneumococcal
infection, IL-1a, KC, and granulocyteemacrophage colony-
stimulating factor expression of mice with preceding hMPV
infection was significantly lower than that of mice without
hMPV infection. Airway IL-10 level of mice with previous
hMPV infection was also lower than that of mice without
hMPV infection at 24 hours after S. pneumoniae infection
(Fig. 6).Discussion
Using the most pathogenic pneumococcal serotypes (ST3
and ST14), this study showed that hMPV-infected A549 cells
expressed increased bacterial adhesion after S. pneumo-
niae inoculation. However, the increase in adherence was
not as significant in Hep-2 cells. A similar cell type-
dependent manner was previously observed.13 A549 and
Hep-2 cells are transformed cell lines of type II alveolar and
nasopharyngeal carcinoma cells, respectively. Thus, A549
cells are more analogous to the epithelial cells of the lower
airway in humans. Therefore, the results indicate the pos-
sibility that enhanced bacterial adherence caused by pre-
ceding hMPV infection is more prominent in the lower
airway.
Using flow cytometry in a fluid phase, increased adher-
ence of S. pneumoniae was found in A549 cells inoculated
with hMPV. Furthermore, to create a more physiologic
condition, a cytometric fluorescence assay was used to
explore the efficacy of adherence of S. pneumoniae in
live monolayer A549 cells. Increased bacterial clumps on
hMPV-infected A549 cells were visualized under confocal
microscopy. Using live FITC-labeled S. pneumoniae, we
further showed that the bronchial epithelium of hMPV-
infected mice was more susceptible to adherence by
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Figure 4. Pulmonary cellular infiltration after Streptococcus
pneumoniae infection. Mice were infected with human meta-
pneumovirus (hMPV-SP) or phosphate buffered saline (SP) at
first and then with S. pneumoniae ST14 5 days later. bron-
choalveolar lavage was performed at 24 hours and 48 hours
after S. pneumoniae infection. Mean and standard deviation
(positive value) of (A) total and (B) differential cell count in
bronchoalveolar lavage fluid are presented. Lower total cell
count and lower neutrophil ration were revealed in hMPV-SP
mice. *p < 0.05 between 2 groups (n Z 4e6).
hMPV increase adherence of Pneumococcus 221S. pneumoniae. These findings indicated that, with pre-
ceding hMPV infection, the adhering bacterial load of
S. pneumoniae was increased in the host.
Kukavica-Ibrulj et al reported that prior infection with
hMPV predisposes mice to exacerbated pneumococcal
infection.17 Their report also showed a profound increase in
lung bacterial titer, up to 1000e10,000-fold, 72 hours after
S. pneumoniae infection. In our report, the increment of
bacterial titers was not that high, waned dramatically at 48
hours postinfection, and almost completely vanished at 72
hours postinfection (data not shown). This may be because
S. pneumoniae ST14, instead of ST3, was used in our ex-
periments in mice. It has been shown that distinct activa-
tion of immune responses was elicited by different strains
of S. pneumoniae.19,20 S. pneumoniae ST3 can cause
delayed bacterial clearance and induce stronger host im-
mune reactions in murine lung.19 Indeed, the inflammatory
responses of the host depend critically on the specific strain
of S. pneumoniae.20
According to our unpublished data and previous study,21
the cytokine/chemokine responses elicited by hMPV
declined dramatically at Day 3 after infection. In Fig. 6,comparable levels of cytokine/chemokine were also
revealed between mice with hMPV infection alone at Day 6
postinfection (hMPV group at 24 hours) and those at Day 7
postinfection (hMPV group at 48 hours).
Efficient recruitment of neutrophils and macrophages
plays an important role in the bacterial clearance of pul-
monary pneumococcal infection.22 Impaired recruitment of
neutrophils in the lung can lead to disturbances of the
host’s immunity to defend against S. pneumoniae infec-
tion.23,24 IL-1a plays an important role in the stimulation of
neutrophil chemokines after bacterial infection,25,26 and
granulocyte-macrophage colony-stimulating factor is
known as a priming factor and chemoattractant of neutro-
phils.27 It appears that IL-1a and TNF-a play overlapping
roles in the innate response to S. pneumoniae infection.28
In mice with preceding influenza infection, impaired
expression of neutrophil chemokines (KC and MIP-2) might
contribute to decreased recruitment of neutrophils after
secondary challenge with S. pneumoniae.29 Expression of
type I interferon, an antiviral response induced by influenza
infection, was believed to contribute to the inhibition of
neutrophil chemoattractants.29 In this study, robust
reduction of neutrophil chemoattractants (IL-1a,
granulocyte-macrophage colony-stimulating factor, and KC)
except for TNF-a was found in mice with preceding hMPV
infection. These results may contribute to the impaired
recruitment of pulmonary neutrophils. However, the role of
type I interferon in the mechanism of post-hMPV pneumo-
coccal pneumonia needs to be addressed further.
The exact mechanism of viral infection enhancing sub-
sequent bacterial adherence is still poorly understood. In
postinfluenza pneumococcal pneumonia, upregulation of
platelet-activating factor receptor and IL-10 was found to
be induced by influenza virus.8,30 Van der Sluijs et al re-
ported that virally infected mice recovering from pneu-
mococcal infection had 50-fold higher levels of IL-10 in the
lung than with controls.30 In their study, the high lethality
was markedly reduced by pretreating the animals with anti-
IL-10 monoclonal antibody. IL-10 is known to inhibit the
expression of major histocompatibility complex class II and
costimulatory molecules and reduce the production of pro-
inflammatory cytokines.31 However, on the contrary, our
results showed lower levels of pulmonary IL-10 and IL-1a in
mice with post-hMPV pneumococcal pneumonia when
compared with mice with only pneumococcal infection.
Thus, we suggest that in contrast to the role of IL-10 in
postinfluenza pneumococcal pneumonia, IL-10 seems to
play a less important role in post-hMPV pneumococcal
pneumonia.
Some notable limitations of this study should be
addressed. First, only two clinical serotype isolates were
tested. Future studies will need to test other common
clinical isolates to confirm the findings of bacterial adher-
ence. Second, this study showed inhibited recruitment of
pulmonary neutrophils after hMPV infection but was unable
to confirm whether this effect resulted directly from
enhanced bacterial proliferation.
In summary, with preceding hMPV inoculation, an
increased adherence of S. pneumoniae was seen in in vitro
airway epithelial cells. A similar finding was noted in the
bronchial epithelium of hMPV-infected mice, which resul-
ted in enhanced bacterial proliferation and exacerbated
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Figure 5. Bacterial loads and histopathologic evaluation of the lungs of mice after Streptococcus pneumoniae infection. Mice
were infected with human metapneumovirus (hMPV-SP) or phosphate buffered saline (SP) at first and then 5 days later with
S. pneumoniae ST14. (A) The mean and standard deviation (positive value) bacterial loads in the lung determined at 24 hours and
48 hours after S. pneumoniae infection. (B) Histopathologic evaluation of the lung with 20 magnification. CFUZ colony-forming
units. (C) The severity of lung inflammation is scored for peribronchial (PB) and perivascular (PV) and represented as mean and
standard deviation (positive value). Delayed bacterial clearance and more severe histopathology were found in lungs of hMPV-SP
mice. *p < 0.05, **p < 0.01, ***p < 0.001 between 2 groups (n Z 4e6).
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hMPV increase adherence of Pneumococcus 223histopathology after pneumococcal infection. In addition,
we suggest that deteriorated lung disease in hMPV-infected
mice might partially result from failure of recruitment of
neutrophils after pneumococcal infection.Conflicts of interest
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